These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10605421)

  • 1. [Favorable long-term outcome with mistletoe therapy in a patient with centroblastic-centrocytic non-Hodgkin lymphoma].
    Kuehn JJ
    Dtsch Med Wochenschr; 1999 Nov; 124(47):1414-8. PubMed ID: 10605421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Favorable long-term outcome with mistletoe therapy in a patient with centroblastic-centrocytic non hodgkin lymphoma].
    Pierach CA
    Dtsch Med Wochenschr; 2000 Aug; 125(31-32):958-60. PubMed ID: 10967963
    [No Abstract]   [Full Text] [Related]  

  • 3. [Subcutaneous manifestations of a centrocytic non-Hodgkin lymphoma at the injection site of a mistletoe preparation].
    Hagenah W; Dörges I; Gafumbegete E; Wagner T
    Dtsch Med Wochenschr; 1998 Aug; 123(34-35):1001-4. PubMed ID: 9739765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
    Grossarth-Maticek R; Ziegler R
    Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group.
    Feuring-Buske M; Kneba M; Unterhalt M; Engert A; Gramatzki M; Hiller E; Trümper L; Brugger W; Ostermann H; Atzpodien J; Hallek M; Aulitzky E; Hiddemann W
    Ann Hematol; 2000 Sep; 79(9):493-500. PubMed ID: 11043420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
    Brittinger G; Bartels H; Common H; Dühmke E; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E; Meusers P
    Hematol Oncol; 1984; 2(3):269-306. PubMed ID: 6384008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study.
    Bar-Sela G; Wollner M; Hammer L; Agbarya A; Dudnik E; Haim N
    Eur J Cancer; 2013 Mar; 49(5):1058-64. PubMed ID: 23218588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador).
    Gorter RW; van Wely M; Stoss M; Wollina U
    Am J Ther; 1998 May; 5(3):181-7. PubMed ID: 10099057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Eur J Med Res; 2008 Mar; 13(3):107-20. PubMed ID: 18499556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Forsch Komplementmed; 2007 Jun; 14(3):140-7. PubMed ID: 17596694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous lesions as the first manifestation of systemic follicular lymphoma in an HIV patient.
    Moreira E; Lisboa C; Alves S; Moreira II; Fonseca E; Azevedo F
    Dermatol Online J; 2008 Jul; 14(7):17. PubMed ID: 18718201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis.
    Grossarth-Maticek R; Ziegler R
    Eur J Med Res; 2006 Nov; 11(11):485-95. PubMed ID: 17182361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of metastatic malignant melanoma with Viscum album extract (Iscador M).
    Kirsch A
    J Altern Complement Med; 2007 May; 13(4):443-5. PubMed ID: 17532738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
    Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R
    Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germinal center cell lymphomas: prognostic significance of their histopathological differentiation.
    König E; Bartels H; Bremer K; Burger-Schüler A; Common H; Dühmke E; Engelhard M; Fülle HH; Gunzer U; Koeppen KM; Leopold H; Nowicki L; Oertel J; Paetzmann S; Rühl U; Schmidt M; Schoengen A; Scholle H; Stacher A; Wolf-Hornung B; Schwarze EW; Brittinger G
    Blut; 1981 Sep; 43(3):193-200. PubMed ID: 7343015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follicular (nodular) non Hodgkin's lymphoma of tonsil--case report].
    Osuch-Wójcikiewicz E; Rzepakowska A; Bruzgielewicz A; Wieczorek J
    Otolaryngol Pol; 2007; 61(2):203-6. PubMed ID: 17668812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas.
    Simon R; Durrleman S; Hoppe RT; Bonadonna G; Bloomfield CD; Rudders RA; Cheson BD; Berard CW
    Ann Intern Med; 1988 Dec; 109(12):939-45. PubMed ID: 3057985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.